Free press releases distribution network?

Agency / Source: tebu-bio

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



tebu-bio Celebrates 10 Years Serving the ADME Community - tebu-bio, today announced its first ADME seminar in Paris to celebrate 10 years serving the ADME-Tox community (October 9th; Maison de la Chimie, France) - tebu-bio.com
tebu-bio Celebrates 10 Years Serving the ADME Community

 

PRZOOM - /newswire/ - Le Perray en Yvelines, Yvelines, France, 2008/07/02 - tebu-bio, today announced its first ADME seminar in Paris to celebrate 10 years serving the ADME-Tox community (October 9th; Maison de la Chimie, France) - tebu-bio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This first ADME seminar, “From in vitro ADME studies to pharmacokinetics prediction”, aims to provide European experts with an overview of the latest technologies in the ADME-Tox and early-ADME fields. Scientists will get an accurate picture of ADME-Tox properties, drug-drug interactions, transporters assessment and pharmacokinetics prediction. The participants will have the opportunity to discuss their upcoming projects and research programs with tebu-bio product specialists and leading world-wide manufacturers (Advancell, Cypex, Noray Bio, Solvo Biotechnology, Xenotech, tebu-bio laboratories).

“We wanted to develop the European ADME-Tox network by creating a forum where experts in the ADME-Tox enviroment can discuss the latest advances in their field.” said Donald van Dijk, CEO of tebu-bio.

“It’s a fantastic opportunity to thank our ADME customers who have worked with us for the last 10 years, since tebu-bio became the first company to introduce cryopreserved hepatocytes in Europe” added Dr Lecommandeur, VP Business Development Manager.

This seminar will take place in the historic French conference centre “La Maison de la Chimie” in Paris (room 201; October 9th, 2008).

Seminar programme, registration form, and accommodation details are available online.

About tebu-bio

tebu-bio (tebu-bio.com) is an expert in the supply and distribution of reagents for Life Sciences research in Europe and has its own R&D laboratories which provide contract services.
tebu-bio is selected as a provider by the most demanding customers and is chosen as a distribution partner by renowned specialized providers. With more than 425,000 specialized reagents, tebu-bio’s on-line catalogue tebu-bio.com is updated daily in the fields of ADME-tox studies but also recombinant protein production, pharmaceutical target validation, molecular screening and cell-based assays. This broad range of reagents and services puts tebu-bio in a strong position to supply the largest international pharmaceutical companies, biotech organizations and Research Institutes in Europe.

tebu-bio: the smarter way to buy research products in Europe

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: tebu-bio

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


tebu-bio Celebrates 10 Years Serving the ADME Community

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Philippe Fixe - tebu-bio.com 
+33(0)1 30 46 39 00 philippe.fixe[.]tebu-bio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any tebu-bio securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From tebu-bio / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today